Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Microba Life Sciences Limited ( (AU:MAP) ) has issued an announcement.
Microba Life Sciences Limited has announced the issuance of 69,444,384 unquoted equity securities, set to expire on August 13, 2027, as part of a placement. This move is part of a previously announced transaction and is not intended to be quoted on the ASX, potentially impacting the company’s financial strategy and stakeholder interests.
The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.33 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.
More about Microba Life Sciences Limited
Microba Life Sciences Limited operates in the life sciences industry, focusing on microbiome analysis and related health solutions. The company is known for its innovative approaches to understanding the human microbiome and its potential impacts on health and wellness.
Average Trading Volume: 327,779
Technical Sentiment Signal: Sell
Current Market Cap: A$46.35M
For detailed information about MAP stock, go to TipRanks’ Stock Analysis page.